Life Sciences
Sunresin Strengthens its Position as a Leader in Ion Exchange Resin Manufacturing by Securing a Key Supplier of DVB

Sunresin’s acquisition of Ningxia Baoyun in China is a key step in supporting continuity of supply for ion exchange resin manufacturing. DVB is a key raw material used in the manufacture of aromatic polymers.

Sunresin has completed the acquisition of 100% of Ningxia Baoyun New Materials Technology Co., Ltd., a Chinese producer of divinylbenzene (DVB) and a longstanding supplier to the company. The acquisition gives Sunresin direct access to a key raw material used in its high-performance adsorption and separation resins.

DVB is a crosslinking monomer used to make the majority of Sunresin’s polymeric adsorption and separation materials, including resins in its Seplife® Life Sciences portfolio. Its quality is particularly important in specialized applications, where resin properties such as swelling behaviour and mechanical strength must meet specific requirements.

Bringing DVB production in-house will allow Sunresin to align raw material specifications more closely with resin requirements, coordinate quality control across both stages of manufacturing and, most importantly, control manufacturing costs.

Established production at industrial scale

Founded in 2019, Ningxia Baoyun operates a modern DVB production line with an annual capacity on the scale of 10,000 tonnes/year. Its established process uses vacuum dehydrogenation of diethylbenzene, followed by distillation and purification, to produce refined DVB at industrial scale.

Sunresin and Ningxia Baoyun have a long history of collaboration, and the acquisition builds on that relationship by integrating Ningxia Baoyun’s production capabilities with Sunresin’s resin development and manufacturing operations.

Supporting supply continuity and new resin development

Owning DVB production capacity helps reduce Sunresin’s exposure to external supply disruptions and raw material price fluctuations. This supports production planning and continuity of supply for resin ranges that depend on DVB, including products used by Life Sciences customers.

The acquisition also supports the development of new high-performance resins for specialized applications. Closer coordination between raw material production and resin development will help Sunresin refine material specifications as new products progress towards industrial manufacturing.

For more information, visit www.sunresinlifesciences.com.

About Sunresin Life Sciences

Sunresin Life Sciences develops and manufactures resin technologies for biomolecule purification, solid-phase synthesis, enzyme immobilization and adsorption. Its teams work with customers in healthcare and life sciences, providing application support from process development through to industrial scale. Its European site in Uppsala, Sweden, houses an R&D and applications laboratory supporting the development of resins and purification processes.

For more information, visit www.sunresinlifesciences.com.

Media inquiries

Javier Peña
Global Marketing Manager, Life Sciences
javier.pena@sunresin-international.com